- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.11. | Argonaut Manufacturing Services Names Rick Hancock as CEO | ||
| 06.11. | Cytiva Launches Fibro dT Platform | ||
| 06.11. | Abzena, Mabqi Enter Strategic Development Services Partnership | ||
| 06.11. | Alvotech, Advanz Pharma Receive MHRA Marketing Authorizations for Gobivaz | ||
| 06.11. | Biovectra, Revolution Biomanufacturing Partner to Streamline mRNA Development & Scale-Up | ||
| 05.11. | Aptamer Expands Multi-Target Optimer Development Program Pact | ||
| 05.11. | Touchlight Expands mbDNA Platform | ||
| 05.11. | Evotec Inks Sale of Just - Evotec Biologics Toulouse Site to Sandoz | ||
| 05.11. | Ailux, Lilly Partner to Advance Bispecific Antibody Development | ||
| 05.11. | Aktis Oncology Appoints Kyle Kuvalanka Chief Financial Officer | ||
| 05.11. | PolyActiva, RareSight Partner to Develop Therapies for Rare Pediatric Retinal Diseases | ||
| 04.11. | Simtra BioPharma Expands U.S. and European Operations to Meet Rising Demand | ||
| 04.11. | Ginkgo Bioworks Awarded mAbs BARDA Project | ||
| 04.11. | Merck Assumes Responsibility for Development of MK-8690 | ||
| 04.11. | Merck & Blackstone Enter Research and Development Funding Agreement | ||
| 04.11. | Kaigene Enters Exclusive Licensing Agreement with Celltrion for KG006 and KG002 | ||
| 04.11. | Magnet Biomedicine Appoints Dr. Bharat Reddy as Chief Business Officer | ||
| 04.11. | Boehringer Ingelheim, CDR-Life Partner to Develop CDR111 for Autoimmune Diseases | ||
| 03.11. | Merck Foundation Launches $22M Initiative Aimed at Improving Cardiovascular Care | ||
| 03.11. | Circle Pharma Appoints Rob Lauzen as CFO | ||
| 03.11. | Sonoma Biotherapeutics Awarded ScaleReady G-Rex Grant | ||
| 03.11. | Sotio Promotes Vivi Boura to Chief Medical Officer | ||
| 03.11. | Roche, Manifold Bio Sign $2B Deal to Develop Next-Gen Brain Shuttles | ||
| 03.11. | Ardena Appoints Chief Quality Officer and Chief Information Officer | ||
| 31.10. | Ajinomoto, Astellas Enter ADC Technology Agreement |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .